Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Takebe

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma developmentJustin Sausville, Alfredo A Molinolo, Xiangfei Cheng, et al.
Human Gene Therapy|April 15, 2003
Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracilGina M Capiaux, Tulin Budak-Alpdogan, Naoko Takebe, et al.
Leukemia Research|May 3, 2005
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascitesYoshio Inoue, Kathrina Chua, Rebecca F McClure, et al.
Seminars in Radiation Oncology|September 14, 2016
Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic CollaborationNaoko Takebe, Mansoor M Ahmed, Bhadrasain Vikram, et al.
Cancer Science|September 30, 2016
Drug induced interstitial lung disease in oncology phase I trialsKan Yonemori, Akihiro Hirakawa, Asuka Kawachi, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Nature Reviews. Clinical Oncology|July 4, 2024
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancerTriparna Sen, Nobuyuki Takahashi, Subhamoy Chakraborty, et al.
Cancer Gene Therapy|September 11, 2004
Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion geneGina M Capiaux, Tulin Budak-Alpdogan, Onder Alpdogan, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Molecular Cancer Therapeutics|March 1, 2006
IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cellsNaoko Takebe, Xiangfei Cheng, Tamer E Fandy, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma developmentJustin Sausville, Alfredo A Molinolo, Xiangfei Cheng, et al.
Human Gene Therapy|April 15, 2003
Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracilGina M Capiaux, Tulin Budak-Alpdogan, Naoko Takebe, et al.
Leukemia Research|May 3, 2005
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascitesYoshio Inoue, Kathrina Chua, Rebecca F McClure, et al.
Seminars in Radiation Oncology|September 14, 2016
Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic CollaborationNaoko Takebe, Mansoor M Ahmed, Bhadrasain Vikram, et al.
Cancer Science|September 30, 2016
Drug induced interstitial lung disease in oncology phase I trialsKan Yonemori, Akihiro Hirakawa, Asuka Kawachi, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
Nature Reviews. Clinical Oncology|July 4, 2024
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancerTriparna Sen, Nobuyuki Takahashi, Subhamoy Chakraborty, et al.
Cancer Gene Therapy|September 11, 2004
Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion geneGina M Capiaux, Tulin Budak-Alpdogan, Onder Alpdogan, et al.
Journal of Hematology & Oncology|February 6, 2015
Notch1 phenotype and clinical stage progression in non-small cell lung cancerDat Nguyen, Larry Rubinstein, Naoko Takebe, et al.
Molecular Cancer Therapeutics|March 1, 2006
IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cellsNaoko Takebe, Xiangfei Cheng, Tamer E Fandy, et al.
Pageof 14